Evaluating the effect of BCG vaccination for non-specific protection from infection in senior citizens during the COVID-19 pandemic: A randomised clinical trial
Open Access
- 17 October 2024
- journal article
- research article
- Published by Elsevier in Journal of Infection
- Vol. 89 (6) , 106319
Abstract
No abstract availableKeywords
Funding Information
- Danmarks Frie Forskningsfond (9039-00231B)
- Region of Southern Denmark (21/18003)
- Cambridge Savings Bank
This publication has 37 references indexed in Scilit:
- Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trialClinical Microbiology and Infection, 2023
- The impact of BCG dose and revaccination on trained immunityClinical Immunology, 2022
- Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trialeClinicalMedicine, 2022
- Bacillus Calmette-Guérin vaccine to reduce healthcare worker absenteeism in COVID-19 pandemic, a randomized controlled trialClinical Microbiology and Infection, 2022
- Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the ElderlyCell, 2020
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19Cell, 2020
- Revaccination with Live Attenuated Vaccines Confer Additional Beneficial Nonspecific Effects on Overall Survival: A ReviewEBioMedicine, 2016
- The Danish Civil Registration System as a tool in epidemiologyEuropean Journal of Epidemiology, 2014
- Trained Immunity: A Memory for Innate Host DefenseCell Host & Microbe, 2011
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009